EGF antibody (AA 971-1023)
Quick Overview for EGF antibody (AA 971-1023) (ABIN7616665)
Target
See all EGF AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 971-1023
-
Purpose
- Epidermal Growth Factor (EGF) Monoclonal Antibody
-
Sequence
- Asn971~Arg1023
-
Characteristics
- The Epidermal Growth Factor (EGF) Monoclonal Antibody (Species: Human) has been validated for the following applications: WB, IHC, ICC, IP.
-
Purification
- Protein A + Protein G affinity chromatography
-
Isotype
- IgG1 kappa
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- 2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
-
Expiry Date
- 12 months
-
-
- EGF (Epidermal Growth Factor (EGF))
-
Alternative Name
- EGF
-
Gene ID
- 1950
-
UniProt
- P01133
-
Pathways
- NF-kappaB Signaling, RTK Signaling, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Regulation of Carbohydrate Metabolic Process, Hepatitis C, Protein targeting to Nucleus, Interaction of EGFR with phospholipase C-gamma, Thromboxane A2 Receptor Signaling, EGFR Downregulation
Target
-